DSIIQ - DelSite, Inc. (PINK Stock)
Rumors are possible merger and results from the H5N1 clinical trial (From Bob at IHUB:
[link removed]
Very interesting that this stock surged just before the S&P and Reuters report.
Each day since 3/3/2010 has had substantial high's and lows.
DelSite still owns more than 130 patents that continue to generate revenue.
03/06/2010 Standard & Poor's -- Quantitative Report released
03/05/2010 Reuters Report -- Financial Summary, 3 year and interim financial, investment profile released
[link removed]
[link removed]
04/03/2009 8-K Filing --
Line 76: DelSite, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite® technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology.
02/03/2009
Line 91: About DelSite, Inc.
DelSite, Inc. is an ISO 9001-certified, research-based, bio-pharmaceutical and consumer products company with a core technology based on naturally-occurring complex carbohydrates. DelSite also manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. DelSite is developing its proprietary GelSite® technology designed to provide controlled release of peptide and protein-based drugs. Its technology is protected by more than 130 patents in 26 countries.
[link removed]
03/08/2010
Mkt cap 73K
03/05/2010
Mkt Cap 85k
03/04/2010
Mkt cap 33K
03/03/2010
Mkt Cap 49K
Date Cap Open High Low Close Volume Chg %Chg Adj. Close
3/3/10 49K 0.001 0.01 0.001 0.0044 2,839,529 0.0034 340.00% 0.0044
3/4/10 33K 0.005 0.006 0.0025 0.003 810,000 -0.0014 -31.82% 0.003
3/5/10 85K 0.0039 0.0079 0.0039 0.0078 773,343 0.0048 160.00% 0.0078
3/8/10 73K 0.008 0.01 0.0045 0.0066 371,500 -0.0012 -15.38% 0.0066
|
Linear Mode
